Download PDFPDF

Acanthamoeba keratitis: confirmation of the UK outbreak and a prospective case-control study identifying contributing risk factors
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Observations on data analysis on acanthamoeba keratitis
    • Ankur Barua, Consultant Ophthalmologist University Hospitals Coventry and Warwickshire
    • Other Contributors:
      • Sunil Shah, Consultant Ophthalmologist

    Dear Editor
    We read the above paper with much interest and welcome the review and analysis of trends in acanthamoeba keratitis – a very important complication from contact lens wear. The paper discusses the incidence of acanthamoeba keratitis at Moorfields Eye Hospital, a large tertiary referral centre.
    We note an incidence of 18.5 cases per annum in 1997-1999, rising to a mean of 50.3 per annum in 2011-2016 and hence has been quite rightly quoted as almost a 3 fold increase in cases.
    We would however suggest some caution when using those figures to state that there is an epidemic at present.
    When one attempts to take into account the fluctuations in numbers of contact lens wearers with the United Kingdom per year and relate that to incidence of acanthamoeba keratitis one has a slightly modified view.1 There has been a steady increase in contact lens wear with figures from the ACLM estimating 4.2 million CL wearers in 2016. A figure has been created showing this relative incidence in a chart format.2
    The figure represents the number of cases diagnosed at Moorfields divided by the number of contact lens users (rising from 1.6 million in 1992 to 4.2 million in 2016). Therefore the mean number of cases when adjusted for CL wearers is 8.5 per year with a standard deviation of 5.8, with 11.8 in 2015 and 14 in 2016.
    Whilst there is still a significant rise in cases, compared to the mainly stable period of 1996-2010, the rates are still lower t...

    Show More
    Conflict of Interest:
    None declared.